Industry news
-
Disruptive tech developers may enjoy new benefits
18 July 2019
The Russian government is considering a package of possible credit benefits for project teams that develop technologies capable of disrupting markets and helping the entire national economy advance, the Russian business daily Kommersant reported . Debates have been active for a month already.
-
Biologists look to “age” cancerous cells
18 July 2019
Scientists at the Moscow Lomonosov State University (MSU) have studied interdependence between the biological mechanisms responsible for premature and natural ageing. To do so, they looked into cells’ nuclear membranes. Based on the results of the study, the researchers are hoping to develop a compound that would thwart the proliferation of cancerous cells in the human body.
-
GlobalData Forecast: B-cell NHL Market Will Reach $9.2bn by 2027
17 July 2019
The B-cell non-Hodgkin’s lymphoma (NHL) market is expected to grow from $5.7bn in 2017 to $9.2bn by 2027 across the seven major markets at a compound annual growth rate (CAGR) of 4.9%, according to GlobalData, a leading data and analytics company.
-
WHO Updated Lists of Essential Medicines and Diagnostics
17 July 2019
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems.
-
True innovation or just later to market? German agency questions benefits of new drugs
16 July 2019
When a new drug is approved, the developer usually trumpets its ability to fill an unmet medical need. But a German agency that evaluates the quality of medical treatments disagrees is calling for an international reform of drug development and approval.
-
EMA’s PRAC Announced Measures to Avoid Dosing Errors
16 July 2019
EMA’s safety committee (PRAC) is recommending new measures to avoid dosing errors that have led to some patients incorrectly taking methotrexate-containing medicines daily instead of weekly.
-
EU and US Fully Implemented MRA for Inspections of Manufacturing Sites
15 July 2019
With the recognition by the US Food and Drug Administration (FDA) of Slovakia, the European Union and the United States have now fully implemented the mutual recognition agreement (MRA) for inspections of manufacturing sites for certain human medicines in their respective territories.
-
Value of the Russian Exports to India Exceeded $1m
15 July 2019
At the Round table “Development of bilateral trade, banking and financial sector and industrial cooperation”, which is taking place on the sidelines of the Second Russia-India Strategic Economic Dialogue in New Delhi, the ways of collaboration between the regulators and further prospects for cooperation are being discussed.
-
Global Guidance on Medicines and Diagnostic Tests Updated by WHO
12 July 2019
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems.
-
Score! 'Good Pharma' ranking finds uptick in new drug data sharing and clinical trial transparency
12 July 2019
Pharma companies are learning to share. That is, when it comes to clinical research data, according to findings from the Good Pharma Scorecard biennial ranking. Now in its third edition, the research found Big Pharma data sharing around clinical research on the upswing, with 95% of patient trials now providing public results within six months of FDA approval. If the time period is extended to 12 months, that improves to 100% for the new drugs reviewed after approval in 2015.
